A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Clinical trial NCT02797977 · COMPLETED
Trial details
- NCT number
- NCT02797977
- Sponsor
- Sierra Oncology LLC - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-04-08
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.